USFDA issues response letter for new drug application for insulin glargine: Biocon
As per the USFDA, a Complete Response Letter (CRL) is sent to an applicant if the agency determines that it will not approve the…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.